CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced that clinical data from its allogeneic BCMA-targeted CAR T-cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback